Brandywine Global Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $6.15M | Sell |
36,197
-584
| -2% | -$89.5K | 0.04% | 338 |
|
|
2025
Q3 | $4.85M | Sell |
36,781
-234,559
| -86% | -$28.1M | 0.03% | 383 |
|
|
2025
Q2 | $28.8M | Sell |
271,340
-119,936
| -31% | -$13M | 0.2% | 129 |
|
|
2025
Q1 | $48.6M | Buy |
391,276
+9,546
| +3% | +$1.25M | 0.35% | 76 |
|
|
2024
Q4 | $47M | Sell |
381,730
-1,390
| -0.4% | -$164K | 0.34% | 83 |
|
|
2024
Q3 | $42.5M | Sell |
383,120
-837
| -0.2% | -$91.7K | 0.28% | 96 |
|
|
2024
Q2 | $41M | Sell |
383,957
-52,600
| -12% | -$5.78M | 0.31% | 87 |
|
|
2024
Q1 | $52.6M | Buy |
436,557
+52,537
| +14% | +$6.44M | 0.38% | 70 |
|
|
2023
Q4 | $47.2M | Buy |
384,020
+26,846
| +8% | +$3.35M | 0.38% | 78 |
|
|
2023
Q3 | $46.2M | Sell |
357,174
-18,176
| -5% | -$2.42M | 0.41% | 75 |
|
|
2023
Q2 | $46.5M | Sell |
375,350
-12,967
| -3% | -$1.74M | 0.39% | 77 |
|
|
2023
Q1 | $56.8M | Buy |
388,317
+46,769
| +14% | +$6.92M | 0.46% | 60 |
|
|
2022
Q4 | $54.4M | Buy |
341,548
+12,437
| +4% | +$1.82M | 0.42% | 65 |
|
|
2022
Q3 | $43.9M | Sell |
329,111
-5,878
| -2% | -$894K | 0.41% | 70 |
|
|
2022
Q2 | $52.3M | Sell |
334,989
-5,126
| -2% | -$789K | 0.45% | 63 |
|
|
2022
Q1 | $52.9M | Sell |
340,115
-9,944
| -3% | -$1.44M | 0.39% | 75 |
|
|
2021
Q4 | $44.6M | Buy |
350,059
+9,170
| +3% | +$1.21M | 0.32% | 92 |
|
|
2021
Q3 | $44.4M | Buy |
340,889
+139,619
| +69% | +$21.1M | 0.34% | 82 |
|
|
2021
Q2 | $35.8M | Sell |
201,270
-62,905
| -24% | -$10.9M | 0.26% | 100 |
|
|
2021
Q1 | $43.4M | Buy |
264,175
+47,074
| +22% | +$7.75M | 0.33% | 80 |
|
|
2020
Q4 | $35.8M | Sell |
217,101
-67,375
| -24% | -$10M | 0.3% | 88 |
|
|
2020
Q3 | $40.6M | Sell |
284,476
-3,501
| -1% | -$434K | 0.4% | 67 |
|
|
2020
Q2 | $31.8M | Buy |
287,977
+48,145
| +20% | +$5.32M | 0.32% | 83 |
|
|
2020
Q1 | $23.9M | Sell |
239,832
-123,064
| -34% | -$15.9M | 0.29% | 79 |
|
|
2019
Q4 | $53.9M | Sell |
362,896
-22,771
| -6% | -$3.1M | 0.38% | 65 |
|
|
2019
Q3 | $49.4M | Sell |
385,667
-6,941
| -2% | -$930K | 0.36% | 67 |
|
|
2019
Q2 | $56M | Buy |
392,608
+83,658
| +27% | +$11.2M | 0.39% | 64 |
|
|
2019
Q1 | $44.2M | Buy |
308,950
+110,351
| +56% | +$14.4M | 0.31% | 81 |
|
|
2018
Q4 | $24.6M | Buy |
198,599
+6,794
| +4% | +$1.01M | 0.18% | 118 |
|
|
2018
Q3 | $32.2M | Sell |
191,805
-5,800
| -3% | -$997K | 0.2% | 112 |
|
|
2018
Q2 | $34M | Sell |
197,605
-8,300
| -4% | -$1.36M | 0.22% | 109 |
|
|
2018
Q1 | $31.1M | Sell |
205,905
-3,171
| -2% | -$465K | 0.2% | 113 |
|
|
2017
Q4 | $28.2M | Sell |
209,076
-6,689
| -3% | -$928K | 0.17% | 117 |
|
|
2017
Q3 | $31.6M | Sell |
215,765
-2,800
| -1% | -$423K | 0.2% | 111 |
|
|
2017
Q2 | $34M | Sell |
218,565
-1,175
| -0.5% | -$180K | 0.22% | 98 |
|
|
2017
Q1 | $31.9M | Sell |
219,740
-15,439
| -7% | -$2.01M | 0.2% | 101 |
|
|
2016
Q4 | $25.6M | Sell |
235,179
-12,900
| -5% | -$1.44M | 0.16% | 122 |
|
|
2016
Q3 | $30.1M | Sell |
248,079
-6,400
| -3% | -$863K | 0.2% | 106 |
|
|
2016
Q2 | $36M | Buy |
254,479
+2,969
| +1% | +$438K | 0.24% | 95 |
|
|
2016
Q1 | $32.8M | Buy |
251,510
+800
| +0.3% | +$99.6K | 0.21% | 99 |
|
|
2015
Q4 | $35.2M | Sell |
250,710
-1,015
| -0.4% | -$141K | 0.22% | 98 |
|
|
2015
Q3 | $33.4M | Buy |
251,725
+57,500
| +30% | +$9.9M | 0.22% | 100 |
|
|
2015
Q2 | $34.2M | Buy |
194,225
+11,550
| +6% | +$2.07M | 0.21% | 98 |
|
|
2015
Q1 | $31.6M | Buy |
182,675
+16,900
| +10% | +$2.9M | 0.2% | 99 |
|
|
2014
Q4 | $27.1M | Buy |
+165,775
| New | +$27.5M | 0.18% | 113 |
|
|
2013
Q4 | – | Sell |
-107,426
| Closed | -$9.88M | – | 997 |
|
|
2013
Q3 | $9.88M | Hold |
107,426
| – | – | 0.1% | 188 |
|
|
2013
Q2 | $7.38M | Buy |
+107,426
| New | +$6.57M | 0.08% | 242 |
|
Other funds holding JAZZ
EC
Brandywine Global Investment Management's JAZZ Position: Q4 2025 in Review
Brandywine Global Investment Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 1.6% in Q4 2025, selling an estimated $89.5K and leaving 36,197 shares worth $6.15M. The position accounts for 0.04% of the portfolio, ranked #338.
Brandywine Global Investment Management first reported a position in JAZZ in Q2 2013 and has held it in 47 quarters since. The position peaked at $56.8M in Q1 2023. 573 funds tracked by Wall St. Rank hold JAZZ as of Q4 2025.
- Brandywine Global Investment Management held 36,197 shares of Jazz Pharmaceuticals worth $6.15M as of Q4 2025.
- Brandywine Global Investment Management sold 584 Jazz Pharmaceuticals shares in Q4 2025, an estimated $89.5K.
- Jazz Pharmaceuticals made up 0.04% of Brandywine Global Investment Management's portfolio in Q4 2025, its #338 holding.
- Brandywine Global Investment Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 47 quarters since.
- Brandywine Global Investment Management's Jazz Pharmaceuticals position peaked at $56.8M in Q1 2023.
- 573 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2025.
Based on Brandywine Global Investment Management's 13F filing for Q4 2025, filed 11 Feb 2026.